Insider Sell: Dwight Gilliland Sells 1,000 Shares of Labcorp Holdings Inc (LH)

Author's Avatar
Dec 04, 2024
Article's Main Image

On December 2, 2024, Dwight Gilliland, a Director at Labcorp Holdings Inc (LH, Financial), sold 1,000 shares of the company, as reported in a SEC Filing. Following this transaction, the insider now owns 7,712 shares of the company. Labcorp Holdings Inc (LH) is a global life sciences company that provides comprehensive clinical laboratory and end-to-end drug development services. The company is known for its extensive network of laboratories and its role in advancing healthcare through diagnostic testing and drug development. 1864339091437547520.png The insider transaction history for Labcorp Holdings Inc indicates that there have been no insider buys over the past year, while there have been 21 insider sells during the same period. This recent sale by Dwight Gilliland is part of the broader trend of insider selling within the company. On the day of the transaction, shares of Labcorp Holdings Inc were trading at $241 each, giving the stock a market cap of $19.863 billion. The company's price-earnings ratio stands at 46.11, which is higher than the industry median of 29.71 and also higher than the company’s historical median price-earnings ratio. 1864339156579282944.png With a trading price of $241 and a GuruFocus Value of $237.38, Labcorp Holdings Inc has a price-to-GF-Value ratio of 1.02, indicating that the stock is fairly valued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated using historical multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also considers a GuruFocus adjustment factor based on the company’s past returns and growth, as well as future estimates of business performance from Morningstar analysts.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.